How we work
We break down the traditional silos across the life-science industry and share information to increase accountability and facilitate progress.
Secretariat: IFPMA serves as the secretariat of the AMR Industry Alliance with the responsibility of implementing the activities endorsed by the Board.
Board: The Board is the governing body of the AMR Industry Alliance. It is responsible for the planning and oversight of AMR Industry Alliance’s activities. Composition:
- R&D Pharma (7)
GlaxoSmithKline plc; F. Hoffmann-La Roche AG; Johnson & Johnson; Merck & Co., Inc.; Pfizer Inc.; Sanofi S.A.; Shionogi & Co. Ltd.
- Biotechs (3)
Achaogen Inc.; Biotech companies in Europe combating AntiMicrobial Resistance (BEAM Alliance); International Council of Biotech Associations (ICBA).
- Generics (3)
Cipla Ltd.; DSM Sinochem Pharmaceuticals; Mylan.
- Diagnostics (3)
AdvaMedDx; bioMérieux S.A.; LabCorp
- Industry Associations (2)
European Federation of Pharmaceutical Industries and Associations (EFPIA); Medicines for Europe
Chair of the Board: Thomas Cueni, Director General, IFPMA
Working Groups dedicated to the 4 action areas: Research & Science, Access, Appropriate Use and Environment